Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cold Therapy to Prevent Paclitaxel-Induced Peripheral Neuropathy and Cutaneous Toxicity

NCT01243541 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01243541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cold Therapy to Prevent Paclitaxel-Induced Peripheral Neuropathy and Cutaneous Toxicity
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Terminated
Start date
November 3, 2010
Completion date
April 4, 2014
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic agent toxicity, pain, peripheral neuropathy, recurrent breast cancer, stage ia breast cancer, stage ib breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer, stage iv breast cancer, therapy-related toxicity